home / / Genmab A/S

Genmab A/S Market Cap

$11.93 B

+0.18 B

OMXCOP:GMAB.CO · April 16, 2025

Share price

$195.69

Enterprise Value

$60.88 B

Change (1-Year)

-24.5%

Global Rank

#1391

Country Rank

Regions

Market cap

As of April 16, 2025, Genmab A/S (GMAB.CO) has a market cap of $11.93 billion USD. According to our data, Genmab A/S is ranked No.1391 in global market value.

Sector Rank:

Biotech #58 Healthcare #22 Pharmaceuticals #55

GMAB.CO Market Capitalization Growth

1 Years Growth:

-24.5%

3 Years Growth:

-42.4%

5 Years Growth:

-2.3%

10 Years Growth:

194.6%

15 Years Growth:

2168.7%

20 Years Growth:

1271.5%

Total Growth:

507%

Genmab A/S Market Cap Chart

YTD

10Y

15Y

20Y

MAX

Genmab A/S Market Cap CAGR Chart

Genmab A/S Market Cap History 2000 - 2025

Year	Market Cap	%Change
Apr 16, 2025	$11.93 B	-16.89%
Dec 30, 2024	$14.35 B	-30.74%
Dec 29, 2023	$20.72 B	-26.73%
Dec 30, 2022	$28.28 B	11.83%
Dec 30, 2021	$25.29 B	6.78%
Dec 30, 2020	$23.69 B	66.25%
Dec 30, 2019	$14.25 B	38.78%
Dec 28, 2018	$10.27 B	3.74%
Dec 29, 2017	$9.90 B	-12.28%
Dec 30, 2016	$11.28 B	27.85%
Dec 30, 2015	$8.82 B	154.65%
Dec 30, 2014	$3.46 B	69.95%
Dec 30, 2013	$2.04 B	172.49%
Dec 28, 2012	$0.75 B	106.91%
Dec 30, 2011	$0.36 B	-42.60%
Dec 30, 2010	$0.63 B	-20.12%
Dec 30, 2009	$0.79 B	-59.61%
Dec 30, 2008	$1.95 B	-34.30%
Dec 28, 2007	$2.97 B	-18.68%
Dec 29, 2006	$3.65 B	181.48%
Dec 30, 2005	$1.30 B	35.00%
Dec 31, 2004	$0.96 B	96.08%
Dec 31, 2003	$0.49 B	108.16%
Dec 31, 2002	$0.24 B	-85.76%
Dec 31, 2001	$1.65 B	-6.01%
Dec 29, 2000	$1.76 B	100%

Similar Companies to Genmab A/S

Name	Market Cap	Market cap difference	Regions
Roche ROG.SW	$249.63 B	38.060 B	Switzerland
Novartis NVS	$217.12 B	0.003 M	Switzerland
Bristol-Myers Squibb BMY	$101.74 B	-0.001 M	USA
Amgen AMGN	$158.77 B	0.132 B	USA
Regeneron Pharmaceuticals REGN	$60.99 B	1.014 B	USA
Gilead Sciences GILD	$131.74 B	-0.002 M	USA
Merck MRK	$197.26 B	0.003 M	USA
AbbVie ABBV	$312.76 B	-0.013 M	USA
AstraZeneca AZN	$210.42 B	-0.005 M	UK
Sanofi SNY	$123.58 B	-0.002 M	France
Eli Lilly LLY	$679.94 B	-0.022 M	USA
Pfizer PFE	$127.27 B	-0.003 M	USA
GlaxoSmithKline GSK	$72.33 B	-0.002 M	UK
Biogen BIIB	$17.12 B	0.000 M	USA
Johnson & Johnson JNJ	$370.20 B	0.003 M	USA

About Genmab A/S Inc.

Name

Genmab A/S

Website

https://www.genmab.com

Headquarters

Copenhagen,None

symbol

GMAB.CO

CURRENCY

DKK

country

fullTimeEmployees

2682

exchange

CPH

firstTradeDateEpochUtc

1970/01/01

GMAB.CO Market Cap Formula

Market Cap	=	GMAB.CO Stock Price	*	GMAB.CO Shares Outstanding
	=	$195.69	*	60.95 M
	=	$11.93 B

What is Market Cap?

Market capitalization represents the market's valuation of a company, calculated by multiplying the current share price by the total number of outstanding shares. It helps to assess the company's size and allows for comparison with other companies.

Material

wikipedia Share_price outstanding

What is Market Capitalization?

Market capitalization, or market cap, is a key measure of a company's market value. It is calculated by multiplying the current stock price by the total number of outstanding shares. Market cap is often used by investors to assess a company's size, stability, and market presence. For any inquiries or to report an issue, please email us at [email protected].

Disclaimer

This website provides general information only. While we aim for accuracy, we do not guarantee data completeness or reliability. Consult a financial advisor before investing. We are not responsible for any losses or damages from using this site. By using it, you agree to these terms. Company logos belong to their respective copyright holders and are shown for editorial purposes only. Prices are not in real time.

America

Europe